Related Experiment Video

Updated: Aug 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Etiologic diagnosis of acute pneumonia in adults: a growing challenge

D N Gerding

    Postgraduate Medicine
    |April 1, 1981
    PubMed

    Insights

    Establishing an etiologic diagnosis for most pneumonia patients is achievable with noninvasive methods. Invasive procedures may be necessary for critically ill or immunocompromised individuals when initial treatments fail.

    Area of Science:

    • Infectious Diseases
    • Pulmonology
    • Medical Diagnostics

    Background:

    • Pneumonia diagnosis often relies on clinical presentation and noninvasive tests.
    • Distinguishing between community-acquired and hospital-acquired pneumonia is crucial.
    • Identifying risk factors like immunosuppression or aspiration is important for patient management.

    Purpose of the Study:

    • To review the diagnostic approaches for pneumonia.
    • To highlight the role of noninvasive and invasive methods in etiologic diagnosis.
    • To discuss the indications and risks associated with invasive diagnostic procedures.

    Main Methods:

    • Review of noninvasive diagnostic techniques including blood and pleural fluid cultures, and serologic titers.
    • Analysis of clinical history for differentiating pneumonia types and identifying at-risk patients.
    • Evaluation of the decision-making process between empiric treatment and invasive diagnostics.

    Main Results:

    • Noninvasive methods are effective for etiologic diagnosis in most pneumonia cases.
    • Blood cultures, pleural fluid cultures, and serologic titers offer high specificity.
    • Clinical history aids in classifying pneumonia and identifying high-risk patients.

    Conclusions:

    • Noninvasive diagnostic methods are sufficient for most pneumonia patients.
    • Invasive procedures are justified for seriously ill and immunocompromised patients when initial therapies fail.
    • Increased knowledge of invasive procedure risks and benefits is essential for physicians treating pneumonia.

    More Related Videos

    Experimental Model to Evaluate Resolution of Pneumonia09:49

    Experimental Model to Evaluate Resolution of Pneumonia

    Published on: February 17, 2023

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...